JPS6283895A - Production of coenzyme q10 - Google Patents

Production of coenzyme q10

Info

Publication number
JPS6283895A
JPS6283895A JP22283485A JP22283485A JPS6283895A JP S6283895 A JPS6283895 A JP S6283895A JP 22283485 A JP22283485 A JP 22283485A JP 22283485 A JP22283485 A JP 22283485A JP S6283895 A JPS6283895 A JP S6283895A
Authority
JP
Japan
Prior art keywords
coenzyme
strain
protomonas
produce
carotenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP22283485A
Other languages
Japanese (ja)
Other versions
JPH0582198B2 (en
Inventor
Sadaji Uragami
貞治 浦上
Makiko Hori
堀 真樹子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Original Assignee
Mitsubishi Gas Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co Inc filed Critical Mitsubishi Gas Chemical Co Inc
Priority to JP22283485A priority Critical patent/JPS6283895A/en
Publication of JPS6283895A publication Critical patent/JPS6283895A/en
Publication of JPH0582198B2 publication Critical patent/JPH0582198B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:To readily, stably and efficiently produce the titled enzyme useful for medicines, etc., by cultivating a variant strain, capable of synthesizing carotenoid and derived from a microorganism of the genus Protomonas having the ability to produce coenzyme Q10. CONSTITUTION:A strain Protomonas extorquens BP-41, etc., is subjected to UV irradiation treatment, etc., to give a variant strain, capable of synthesizing carotenoid and having increased ability to produce coenzyme Q10, e.g. Protomonas extorquens DB-100, etc., which is then cultivated in a culture medium consisting of a carbon source L-arabinose, nitrogen source peptone, inorganic salt iron salt, growth promoting substance amino acid, etc., at 20-40 deg.C and 6-8pH by a batch culture method, etc., to produce and accumulate the coenzyme Q10 in microbial cells. The culture fluid is then subjected to centrifugal separation, etc., to separate and recover the microbial cells, which are extracted with methanol, etc., separated and purified to isolate and aimed coenzyme Q10 expressed by the formula.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、助酵素Q10の製造法に関し、さらに詳細に
は、微生物を使用した助酵IQ、oの製造法に係わる。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing coenzyme Q10, and more particularly to a method for producing cofermented IQ,o using microorganisms.

助酵素Q10は、下に示される構造式含有し、生体内の
末端呼吸系の電子伝導体として重要な役割を果し、心臓
機能大進剤、膵機能冗進剤、重症筋無力症治療剤、肺気
腫治療剤、再生不良性貧血治療剤および円形脱毛症治療
剤などの医薬品ならびに飼料添加剤として有用な化合物
である。
Coenzyme Q10 has the structural formula shown below and plays an important role as an electron conductor in the terminal respiratory system in vivo, and is used as a cardiac function enhancer, pancreatic function enhancer, and myasthenia gravis treatment agent. It is a compound useful as a pharmaceutical agent such as a therapeutic agent for emphysema, a therapeutic agent for aplastic anemia, and a therapeutic agent for alopecia areata, and as a feed additive.

〔従来技術、発明が解決しようとする問題点〕従来、助
酵素Q、oは、微生物、動物または植物の組織から抽出
し、さらに精製することにより製造されている。また、
近年、微生物を培養して得られた菌体より助酵素Q、o
を抽出する方法も知られている。
[Prior Art and Problems to be Solved by the Invention] Conventionally, coenzymes Q and O have been produced by extracting them from microbial, animal or plant tissues and further purifying them. Also,
In recent years, coenzymes Q and o have been obtained from bacterial cells obtained by culturing microorganisms.
There are also known methods for extracting.

しかしながら、微生物の含有する助酵素Q、。However, coenzyme Q contained in microorganisms.

含有量は比較的低く、工業的に生産するためには、助酵
素Q の含有量が一段と多い菌の取得が望まれる。
The content is relatively low, and for industrial production, it is desirable to obtain bacteria with a higher content of coenzyme Q.

本発明者らは一1変異処理による助酵素Q の高含有菌
株の取得を目的とした。
The present inventors aimed to obtain a bacterial strain with a high content of coenzyme Q by the 11 mutation treatment.

〔問題を解決するための手段、作用〕[Means and actions for solving problems]

本発明者らは、助酵素Q を多址に生産する変異株を見
出すべく研究を重ねた結果、プロトモナス属に属する菌
株を変異処理し、力pチノイド合成能変異株−力ロチノ
イド増加株、カロチノイド減少株、あるいはカロチノイ
ド欠失株−を取得することにより、助酵素Q、。を多量
に含有する菌株を取得することに成功し、本発明を完成
した。すなわち、本発明は、プロトモナス属に属し、か
つ助酵素Q、。生産能を有する微る。
As a result of repeated research to find mutant strains that produce coenzyme Q in large quantities, the present inventors mutated a strain belonging to the genus Protomonas, resulting in a mutant strain capable of synthesizing p-tinoids, a strain with an increased ability to synthesize carotenoid, and a strain with increased carotenoid production. coenzyme Q by obtaining a reduced strain or a carotenoid-deficient strain. We succeeded in obtaining a strain containing a large amount of , and completed the present invention. That is, the present invention relates to coenzyme Q, which belongs to the genus Protomonas. It has a small production capacity.

本発明において使用される菌株の親株は、胞子を形成せ
ず、ピンクコロニーを形成し、極ベン毛を有するメタノ
ール資化性のダラム陰性桿Pseudomonas、 
Pro taminobac ter、 Mycop 
1ana。
The parent strain of the strain used in the present invention is a methanol-assimilating Durham-negative rod Pseudomonas that does not form spores, forms pink colonies, and has polar Ben hairs.
Pro taminobacter, Mycop
1ana.

Th1obacillus属と 呼ばれた1群に属する
菌株である。これらの菌株は、浦上と駒形とにより+9
84年Protomonas属細菌として提案されてい
る( International Journal 
ofSystematic  Bacteriolog
y、第34巻−第188−201頁、1984年)。
This strain belongs to a group called the Th1obacillus genus. These strains were +9 by Urakami and Komagata.
In 1984, it was proposed as a bacterium of the genus Protomonas (International Journal
of Systematic Bacteriology
y, Vol. 34-pp. 188-201, 1984).

変異処理方法としては、特に制限はないが、実用上、通
常行なわれているUV処理、N−メチル−N’−ニド田
−N−ニド−ソゲ7ニジン(NTG)処理およびエチル
メタノサルファネー)(EMS)処理などが好ましい。
There are no particular restrictions on the mutation treatment method, but UV treatment, N-methyl-N'-nido-N-nido-N-nido-sogen (NTG) treatment, and ethylmethanosulfanalyte treatment, which are commonly used in practice, are not particularly limited. (EMS) treatment is preferred.

カロチノイド合成能変異株は、変異処理した菌液を寒天
培地上で培養し、生じたコロニーのピンク色の濃さの変
化により選択することにより取得される。
The carotenoid-synthesizing mutant strain is obtained by culturing the mutagenized bacterial solution on an agar medium and selecting based on changes in the pink color density of the resulting colonies.

たとえばプロトモナス エクストルフェンスBP−41
(微工研菌寄第4896号)から、助酵素Q 生産能が
増加した変異株として、たとえば、カロチノイド増加法
であるプロトモナス エクストルフェンス DB−10
0(を工研菌寄第8590号)およびカロチノイド欠失
株である同DB−1115(微工研菌寄第8391号)
が誘導される。また、同1)33−1115から、助#
素Q 生産能が増加した変異株として、たとえばカロチ
ノイド増加法である同HB−5(微工研薗寄第8392
号)および同HB−8(微工研菌寄第8395号)がそ
れぞれ誘導される。
For example, Protomonas extorfens BP-41
(Feikoken Bacteria Serial No. 4896), as a mutant strain with increased coenzyme Q production ability, for example, Protomonas extorfens DB-10, which is a carotenoid increase method.
0 (Koken Bokuyori No. 8590) and the carotenoid deletion strain DB-1115 (Koken Bokuyori No. 8391).
is induced. Also, from 1) 33-1115, assistant #
As a mutant strain with increased production ability of MotoQ, for example, HB-5 (Feikokenzonoyo No. 8392), which is a carotenoid increasing method, is used.
(No. 8395) and HB-8 (Feikoken Bibori No. 8395) are respectively induced.

これらの変異株の直学的性質はカロチノイド合成能が変
化せしめられ°かつ助酵素Q、oの生産能が増大せしめ
られた以外にはプロトモナスエクストルフェンス Bp
−41と実質的ニ異るところはない。
The direct properties of these mutant strains are that the ability to synthesize carotenoids was changed and the ability to produce coenzymes Q and O was increased.
There is no substantial difference from -41.

なお、プロトモナス エクストルフェンスれた菌株であ
ったが、浦上と駒形との論文中でプロトモナス エクス
トルフェンスとして再同変異株スクリーニング用培地は
親株および変異株の両者が生育、増殖しうる培地であれ
ばよく特に制限はない。また、変異株増殖用培地すなわ
ち補酵素Q 生産用培地は変異株が増殖しうる培地であ
ればよく、これまた特に制限はない。すなわち炭素源、
窒素源および無機塩さらに必要に志じて生育促進物質な
どを含有する通常の培地が使用される。
In addition, although the strain was identified as Protomonas extorfens, in the paper by Uragami and Komagata, the medium for screening the same mutant strain was a medium in which both the parent strain and the mutant strain could grow and proliferate. There are no particular restrictions. The medium for growing the mutant strain, ie, the medium for producing coenzyme Q, may be any medium that allows the growth of the mutant strain, and is not particularly limited. i.e. carbon source,
Conventional media containing nitrogen sources, inorganic salts, and, if necessary, growth-promoting substances, are used.

炭素源としては、これらの細菌が資化しうろものであれ
ばいずれでもよ<、L−7ラビノース、D−キシロース
、D−マンノース、D−フラクトース、ガラクトース、
グリセロール、コハク酸、クエン酸、酢酸およびメタノ
ールなどをそれぞれ単独あるいは組合わせて使用するこ
とが出来る。これらのうち、実用上、メタノールが好ま
しい。
Any carbon source that can be assimilated by these bacteria may be used, such as L-7 rabinose, D-xylose, D-mannose, D-fructose, galactose,
Glycerol, succinic acid, citric acid, acetic acid, methanol, and the like can be used alone or in combination. Among these, methanol is practically preferred.

窒素源としては、硫酸アンモニウム、尿素、硝fi7ン
モニウム、りん酸アンモニウム、ペプトン、肉工牛スな
どが用いられる。無機塩類としては、抄ん酸塩、マグネ
シウム塩、鉄塩、その他必要に応じて微量金属塩が用い
られる。生育促進物質としては、たとえばアミノ酸、核
酸、ビタミン、酵母エキスおよび麦芽エキスなどが使用
される。また、使用菌株が栄養要求性を示す場合には、
その要求性物質を培地に添加する。
As the nitrogen source, ammonium sulfate, urea, ammonium nitrate, ammonium phosphate, peptone, beef stock, etc. are used. As the inorganic salts, citrate salts, magnesium salts, iron salts, and other trace metal salts are used as necessary. Examples of growth-promoting substances used include amino acids, nucleic acids, vitamins, yeast extracts, and malt extracts. In addition, if the strain used is auxotrophic,
The auxotrophic substance is added to the medium.

培養条件は、温度20〜40℃の範囲で、各菌株にとっ
て、生育、増殖に適した温度を選択すればよい。培ip
Hは、通常6〜8の範囲で各菌株にとって生育、増殖に
適したpH1i−選択する。培養方式は1回分培養ある
いは連続培養のいずれでもよい。窒素源として、アンモ
ニウム塩を使用する場合は、菌体が増殖するに伴って培
養液中のpHが低下するので、培養期間中 −の培地の
pHを一定に保つために、アンモニア、苛性カリ、もし
くは苛性ソーダなどを添加して、培養液のpHを調節す
る必要がある。これらの中でアンモニアが特に好ましい
As for the culture conditions, a temperature suitable for growth and proliferation of each strain may be selected within a temperature range of 20 to 40°C. culture ip
H is usually selected from a pH range of 6 to 8, which is suitable for the growth and proliferation of each strain. The culture method may be either batch culture or continuous culture. When using ammonium salt as a nitrogen source, the pH of the culture medium decreases as the bacterial cells multiply, so in order to keep the pH of the medium constant during the culture period, ammonia, caustic potassium, or It is necessary to adjust the pH of the culture solution by adding caustic soda or the like. Among these, ammonia is particularly preferred.

このようにして、m*を培養した後、菌体を培養液より
分離回収する。菌体の分離回収には。
After culturing m* in this manner, the bacterial cells are separated and recovered from the culture solution. For isolation and recovery of bacterial cells.

通常の固液分離手段が採用される。たとえば、培養液を
そのまま遠心分離する方法、培養液中に本細醒よりも大
きい他の微生物の細胞をろ過助剤として加えたり、ある
いはプレコートすることにより培養液から菌体をろ過分
離する方法、培養液に種々の凝集剤を加え菌体を凝集さ
せ、これをろ過あるいは遠心分離により培養液から菌体
を分離する方法および培養液のpHを5以下にすること
により、あるいはpHを5以下にし、さらに50〜10
0℃で加熱することによ抄菌体を分離する方法などを適
用しうる。分離された菌体は、そのまま、あるいは9t
M乾燥機などにより乾燥され、以下の助酵素Q、。の抽
出、精製が行なわれる。
Conventional solid-liquid separation means are employed. For example, a method of centrifuging the culture solution as it is, a method of adding cells of other microorganisms larger than the present microorganism to the culture solution as a filter aid, or a method of filtering and separating bacterial cells from the culture solution by pre-coating. A method in which various flocculants are added to the culture solution to aggregate the bacterial cells, and the bacterial cells are separated from the culture solution by filtration or centrifugation. , further 50-10
A method of separating the microbial cells by heating at 0° C. can be applied. The isolated bacterial cells can be used as is or in 9t
The following coenzyme Q is dried using an M dryer or the like. Extraction and purification are performed.

助酵素Q の分離・抽出唸、常法に従って行なうことが
できる。たとえば、エタノールに菌体を懸濁させて、5
0〜90℃で1〜数時間加熱抽出する。あるいは、まず
メタノール、水酸化ナトリウムおよびピーガp−ルの混
合物を用いて、菌体中の抄ん脂質などのけん化性物質を
けん化し、このけん化液からn−へキサンの如き、水と
混合しない有機溶媒を加えて、助酵素Q1oを抽出する
。ついでこの抽出物をシリカゲルおよびフ四リジルなど
を用いて分別精製を行なって単離する。
Separation and extraction of coenzyme Q can be carried out according to conventional methods. For example, suspending bacterial cells in ethanol and
Heat extraction at 0 to 90°C for 1 to several hours. Alternatively, first use a mixture of methanol, sodium hydroxide, and Pigal-pol to saponify saponifiable substances such as paper lipids in the bacterial cells, and from this saponified liquid, extract a substance that does not mix with water, such as n-hexane. Add an organic solvent to extract coenzyme Q1o. This extract is then isolated by fractional purification using silica gel, futridyl, and the like.

菌体から得られた助酵素Q、。の同定には、一般に高速
液体クロマトグラフィー、元素分析、融点測定、赤外部
および紫外部吸収スペクトル、核磁気共鳴スペクトルな
らびにff、1分析などの手段がそれぞれ用いられる。
Coenzyme Q obtained from bacterial cells. For identification, means such as high performance liquid chromatography, elemental analysis, melting point measurement, infrared and ultraviolet absorption spectra, nuclear magnetic resonance spectroscopy, and ff, 1 analysis are generally used.

〔実施例〕〔Example〕

実施例によって本発明をさらに具体的に説明する。 The present invention will be explained in more detail with reference to Examples.

実施例 純水11あた抄、(NH4)2S043g、KH2PO
4164g、NazHt’042.1g、Mg5O<−
7HzOO,29%CaC1w・2H203oq、Fe
(jHsoy −XH2030■、MnCl2−4H2
05m?、 Zn5Oa・7H205■、CuSO4・
5H200、5W、酵母エキス0.2g、パントテン酸
カルシウム 4■およびメタノール 8プを浴解し、p
Hが7.1に調整された培地(以下 培地B と記す)
で30℃、18 時間生育させたプロトモナス エクス
トルフェンス BP−4+  の[体t−1N−メチル
−N’−ニトロ−N−二トロングアニジン0.5ダ/−
を含む0.1Mりん酸緩衝液(pH7,0)中に10 
個/ゴとなるように懸濁し、30℃で30分間振盪した
。その後、遠心分離で集菌した菌体を0.1Mりん酸緩
衝液(pH7,0)で洗浄した後、この菌体を0.1M
りん酸緩衝液に再度懸濁させた菌体懸濁液(108個/
ml ) o 、  1−を培地B101dK接種し。
Example pure water 11 Atasho, (NH4)2S043g, KH2PO
4164g, NazHt'042.1g, Mg5O<-
7HzOO, 29%CaC1w・2H203oq, Fe
(jHsoy-XH2030■, MnCl2-4H2
05m? , Zn5Oa・7H205■, CuSO4・
5H200, 5W, yeast extract 0.2g, calcium pantothenate 4■ and methanol 8p were dissolved in a bath, and p
Medium with H adjusted to 7.1 (hereinafter referred to as medium B)
Protomonas extorfens BP-4+ grown for 18 hours at 30°C was treated with 0.5 Da/-
10 in 0.1 M phosphate buffer (pH 7,0) containing
The mixture was suspended at a ratio of 50% to 50%, and shaken at 30°C for 30 minutes. After that, the bacterial cells collected by centrifugation were washed with 0.1M phosphate buffer (pH 7.0), and the bacterial cells were washed with 0.1M phosphate buffer (pH 7.0).
Cell suspension resuspended in phosphate buffer (108 cells/
ml) o, 1- was inoculated into medium B101dK.

2日間培養を行なった。Culture was performed for 2 days.

この培養液 0.1Mを生理食塩水で希釈後、寒天平板
培地(培地Bに2 wt96となるように寒天を添加)
上に塗布し、4日間培養を行ない、コロニーのピンク色
の濃さによりカロチノイド合成変異株を選択し、単離し
た。
After diluting 0.1M of this culture solution with physiological saline, agar plate medium (agar was added to medium B to give a concentration of 2wt96)
After culturing for 4 days, carotenoid-synthesizing mutants were selected and isolated based on the intensity of pink color of the colonies.

これらの変異株の中より、助酵素Q の含量の増加した
変異株として、カロチノイド増加株であるプートモナス
 エクストルフェンス DB−100(微工研菌寄第8
390号)、カロチノイド欠失株でらる同1)B−11
15(徴工研菌寄第8391号)を得た。
Among these mutant strains, we selected Putomonas extorfens DB-100 (FeI-Ken Bacterial Collection No. 8
390), carotenoid deletion strain 1) B-11
15 (Choken Bacteria No. 8391) was obtained.

さらに、助酵素Q 含量を増加させるために、プロトモ
ナス エクストルフェンス DB−1115を親株とし
て前記と同じ方法で再度変異処理を行なった。寒天培地
(培地B)で4日間培養を行ない、コーニーのピンク色
の濃さの変化からカロチノイドの増加した力pチノイド
合成変異株を単離した。
Furthermore, in order to increase the coenzyme Q content, mutation treatment was performed again using Protomonas extorfens DB-1115 as the parent strain in the same manner as above. Cultivation was carried out on an agar medium (medium B) for 4 days, and a ptinoid-synthesizing mutant strain with increased carotenoid content was isolated based on changes in the intensity of the pink color of Corny.

これらの変異株の中より、助酵素Q、oの含量がさらに
増加した変異株として、カロチノイド増加株である同H
B−5(微工研菌寄第8392号)および同HB−8(
微工研菌寄第8393号)を得た。
Among these mutant strains, the mutant strain with increased content of coenzymes Q and O is the same strain with increased carotenoid content.
B-5 (Feikoken Bibori No. 8392) and HB-8 (
8393) was obtained.

培地Bを用いて50℃で3日間前培養された各菌株の培
養液を培地Bにそれぞれ1容量%接種し、30℃で回転
振とう培養を行なった。培養開始後48時間で培養液中
のメタノール濃度は0,001wt96以下となった。
The culture solution of each strain precultured at 50°C for 3 days using medium B was inoculated at 1% by volume into medium B, and cultured with rotary shaking at 30°C. 48 hours after the start of culture, the methanol concentration in the culture solution became 0,001wt96 or less.

この培養液wt96インプロパノール水溶液4抽出し、
ヘキサン転溶を行ない、さらに得られたへ牛サン溶液中
の還元型助酵素Q を硝酸鉄で酸化したのち、とのへ牛
サン溶液中の助酵素Q の含量を測定した。またカロチ
ノイド含量も測定した。
Extract this culture solution wt96 inpropanol aqueous solution 4,
After carrying out hexane transfer and further oxidizing the reduced coenzyme Q in the resulting hexan beef san solution with iron nitrate, the content of coenzyme Q in the hexan san solution was measured. Carotenoid content was also measured.

結果を第1表に示す。The results are shown in Table 1.

第1表 〔発明の効果〕 本発明によれば、細菌を利用して、助酵素Q、。Table 1 〔Effect of the invention〕 According to the present invention, coenzyme Q is produced using bacteria.

を容易にかつ安定的に効率よく得ることが可能であり、
しかも工業生産される化学物質をも原料として使用しう
る。
can be obtained easily, stably and efficiently,
Furthermore, industrially produced chemical substances can also be used as raw materials.

特許出願人  三菱瓦斯化学株式会社 代表者長野和吉Patent applicant: Mitsubishi Gas Chemical Co., Ltd. Representative Kazuyoshi Nagano

Claims (1)

【特許請求の範囲】[Claims] プロトモナス属に属し、かつ、助酵素Q_1_0生産能
を有する微生物から誘導されたカロチノイド合成能変異
株を培養して得られた菌体より助酵素Q_1_0を採取
することを特徴とする、助酵素Q_1_0の製造法。
coenzyme Q_1_0, which is characterized in that coenzyme Q_1_0 is collected from the bacterial cells obtained by culturing a carotenoid synthesizing mutant strain derived from a microorganism belonging to the genus Protomonas and having coenzyme Q_1_0 producing ability. Manufacturing method.
JP22283485A 1985-10-08 1985-10-08 Production of coenzyme q10 Granted JPS6283895A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22283485A JPS6283895A (en) 1985-10-08 1985-10-08 Production of coenzyme q10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22283485A JPS6283895A (en) 1985-10-08 1985-10-08 Production of coenzyme q10

Publications (2)

Publication Number Publication Date
JPS6283895A true JPS6283895A (en) 1987-04-17
JPH0582198B2 JPH0582198B2 (en) 1993-11-17

Family

ID=16788639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22283485A Granted JPS6283895A (en) 1985-10-08 1985-10-08 Production of coenzyme q10

Country Status (1)

Country Link
JP (1) JPS6283895A (en)

Also Published As

Publication number Publication date
JPH0582198B2 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
CN116716231B (en) Escherichia coli and application thereof in fermentation production of tryptophan
JPH05227980A (en) Production of vanillin and its related compound by fermentation
JP3981597B2 (en) Method for producing scyllo-inosose and method for producing scyllo-inositol
JPS6283895A (en) Production of coenzyme q10
JPS6283894A (en) Production of coenzyme q11
JPS6336789A (en) Production of coenzyme q10
JPS6155955B2 (en)
JPS5923794B2 (en) Manufacturing method of dihydroxyacetone
JPH0838188A (en) Production of inositol and method for taking glucose metabolism antagonistic substance-resistant strain
JPH04304893A (en) Production of hydroxide of nitrogen-containing heterocyclic compound by microorganism
JP3007453B2 (en) Method for producing zeaxanthin
JPS5920359B2 (en) Production method of polylysine
JP4262528B2 (en) (-)-Method for producing Vivo-Quercitol
JP3025067B2 (en) Method for producing glyoxalase I
JPH1042860A (en) Production of inositol and acquirement of hexachlorocyclohexane-resistant strain
JPH1042883A (en) Production of inositol and collection of strain resistant to 6-halogeno-6-deoxyglucose
JPH01104194A (en) Production of d-(-)-tartaric acid
JPS62190095A (en) Production of coenzyme q11
JP2901458B2 (en) Method for producing gentianose
JPH04304894A (en) Production of hydroxide of picolinic acid or pyrazinic acid by microorganism
SU910617A1 (en) Process for producing nicotinic acid
JPH0523250B2 (en)
JPH01252295A (en) Production of 2,3-dicyano-5,6-dicyanopurazine
JPH1160608A (en) Preparation of high purity hyaluronic acid or salt thereof
JPH0533989B2 (en)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term